|
⚲
|
| Keyboard |
| Harland John M
✚
|
|
|---|---|
| CIK # | 0001546788 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001546788] | |
| 4 | [0001546788] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Harland John M | |
| NABI Biopharmaceuticals | |
| WaferGen Bio-systems Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2018-09-11 | Other | 761 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2018-05-25 | Grant | 18,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2018-02-13 | Grant | 9,563 | ||
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2018-02-13 | Grant | 7,047 | ||
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2018-02-13 | Grant | 8,255 | ||
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2018-02-13 | Grant | 4,087 | ||
|
WaferGen Bio-systems Inc WGBS
Stock Option (right to buy) · derivative
|
2012-05-17 | Grant | 550,000 | $0.00 |